Cutera, Inc. is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers. Each of its laser and other energy-based platforms consists of one or more hand pieces and a console that incorporates a universal graphical user interface, a laser or other energy-based module, control system software and high voltage electronics. enlighten is a dual wavelength (1,064 nanometer + 532 nanometer) and dual pulse duration (750 picosecond (ps) and 2 nanosecond (ns)) laser system. excel V is a vascular and benign pigmented lesion treatment platform designed for the core-market of dermatologists and plastic surgeons.
Company Growth (employees)
Type
Public
HQ
Brisbane, US
Founded
1998
Size (employees)
297 (est)+14%
Website
cutera.com
Cutera was founded in 1998 and is headquartered in Brisbane, US

Cutera Office Locations

Cutera has offices in Brisbane, Tokyo, Lieusaint, Schaarbeek and in 3 other locations
Brisbane, US (HQ)
3240 Bayshore Blvd
Hertfordshire, GB
Broadway Letchworth Garden City
Barcelona, ES
429 Avinguda Diagonal
Zürich, CH
27 Zollikerstrasse
Schaarbeek, BE
80 Auguste Reyerslaan
Lieusaint, FR
1 Rue Georges Charpak
Show all (7)

Cutera Financials and Metrics

Cutera Financials

Cutera's revenue was reported to be $118.1 m in FY, 2016
USD

Revenue (Q2, 2017)

36.4 b

Gross profit (Q2, 2017)

21 b

Gross profit margin (Q2, 2017), %

58%

Net income (Q2, 2017)

1.9 b

EBIT (Q2, 2017)

1.7 b

Market capitalization (13-Nov-2017)

629.8 m

Cash (30-Jun-2017)

18.7 m
Cutera's current market capitalization is $629.8 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

74.6 m78.1 m94.8 m118.1 m

Revenue growth, %

5%21%25%

Cost of goods sold

32.7 m34.8 m40.5 m49.9 m

Gross profit

41.9 m43.4 m54.3 m68.1 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

16.8 m16.2 m17.7 m18.7 m19.1 m22.6 m23.1 m22.4 b27.5 b30.3 b29.3 b36.4 b

Cost of goods sold

7.7 m7.3 m7.8 m7.9 m9.1 m9.7 m9.6 m9.9 b11.5 b12.5 b13.8 b15.3 b

Gross profit

9.2 m8.9 m9.9 m10.8 m10 m12.9 m13.5 m12.5 b16 b17.7 b15.5 b21 b

Gross profit Margin, %

55%55%56%58%53%57%58%56%58%59%53%58%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

16.2 m9.8 m10.9 m13.8 m

Accounts Receivable

1.6 m

Inventories

9 m11 m12.1 m15 m

Current Assets

103.3 m104.9 m73.8 m87.8 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

15.2 m10.7 m10.9 m11.4 m13.5 m11.6 m10.1 m6.3 m7.4 m11.3 m11.4 m18.7 m

Accounts Receivable

7.5 m6.6 m7.6 m8.7 m10.4 m8.9 m9 m11.2 m11.2 m11.7 m17.9 m18.2 m

Inventories

10.4 m9.6 m10 m11.1 m11.9 m13.5 m13.5 m13.5 m14.7 m16.5 m15.7 m16.9 m

Current Assets

101.8 m102.5 m101 m102.5 m100 m90.4 m72.3 m71 m71.8 m77 m84.4 m91.2 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(4.7 m)(10.6 m)(4.4 m)2.6 m

Depreciation and Amortization

1.3 m1.3 m1.2 m982 k

Accounts Receivable

(857 k)(1.5 m)(536 k)(4.9 m)

Inventories

2.1 m(2 m)(1.1 m)(2.9 m)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

(1.7 m)(3.6 m)(2.7 m)(2.6 m)(3.6 m)(1.9 m)(957 k)(2.1 b)(1.2 b)1.6 b(1 b)

Accounts Receivable

7.6 m8.7 m10.4 m8.9 m9 m11.2 m11.2 m11.7 m17.9 m

Inventories

10 m11.1 m11.9 m13.5 m13.5 m13.5 m14.7 m16.5 m15.7 m

Accounts Payable

2 m2.7 m2.9 m3.6 m2.7 m2.6 m2.8 m3.3 m3.1 m
Y, 2017

Financial Leverage

1.6 x
Show all financial metrics

Cutera Market Value History

Cutera's Web-traffic and Trends

Cutera Online and Social Media Presence

Cutera News and Updates

Dermatology Diagnostic Device Market 2017 Estimated for Aggrandized Growth by 2022

The Analysis displays the investigation of Worldwide Dermatology Diagnostic Device encouraging the territorial and nation shrewd examination covering the key examination of each market player and the piece of the overall industry they hold Posted via Industry Today. Follow us on Twitter @IndustryTod…

Cosmetic Surgery Market U.S $ 21.97 Billion Projected At CAGR ~7.8% Expected to Reach by 2023

The Global cosmetic surgery market is segmented on the basis of surgery type. Based on the surgery type, the market has been segmented as liposuction, eyelid and nose surgery, body contouring, facial reconstruction, cosmetic implants and others. Posted via Industry Today. Follow us on Twitter @Indu…

Aesthetics Combination Therapy Market Estimated to Exhibit at 8% CAGR during 2016-2024

The global aesthetics combination therapy market was valued at US$ 1.97 Bn in 2016, and a new report from Persistence Market Research anticipates it to reach US$ 3.69 Bn by 2024. Posted via Industry Today. Follow us on Twitter @IndustryToday

Cutera Company Life and Culture

You may also be interested in